Owlet, Inc. (OWLT)
USD 4.46
(-4.9%)
USD 4.46
(-4.9%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -27.48 Million USD | 68.73% |
| 2022 | -75.53 Million USD | -50.89% |
| 2021 | -42.7 Million USD | -789.74% |
| 2020 | -8.24 Million USD | 61.87% |
| 2019 | -16.5 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.77 Million USD | -145.51% |
| 2024 Q1 | -5.28 Million USD | 162.79% |
| 2023 Q3 | -7.88 Million USD | -26.91% |
| 2023 FY | - USD | 68.73% |
| 2023 Q4 | -2.61 Million USD | 66.87% |
| 2023 Q2 | -6.2 Million USD | 43.55% |
| 2023 Q1 | -11 Million USD | 46.86% |
| 2022 Q4 | -20.7 Million USD | 3.54% |
| 2022 Q3 | -21.46 Million USD | -5.71% |
| 2022 Q1 | -21.3 Million USD | 36.6% |
| 2022 FY | - USD | -50.89% |
| 2022 Q2 | -20.3 Million USD | 4.7% |
| 2021 Q1 | -2.57 Million USD | 23.39% |
| 2021 Q4 | -33.6 Million USD | -150.65% |
| 2021 Q3 | -13.4 Million USD | -131.32% |
| 2021 FY | - USD | -789.74% |
| 2021 Q2 | -5.79 Million USD | -124.79% |
| 2020 Q1 | -1.71 Million USD | 0.0% |
| 2020 Q4 | -3.36 Million USD | -199.11% |
| 2020 Q3 | -1.12 Million USD | -165.33% |
| 2020 Q2 | -424 Thousand USD | 75.26% |
| 2020 FY | - USD | 61.87% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Abbott Laboratories | 10.46 Billion USD | 100.263% |
| Allurion Technologies Inc. | -69.03 Million USD | 60.179% |
| Artivion, Inc. | 38.14 Million USD | 172.07% |
| Avanos Medical, Inc. | 53.2 Million USD | 151.671% |
| Butterfly Network, Inc. | -124.84 Million USD | 77.981% |
| Butterfly Network, Inc. | -124.84 Million USD | 77.981% |
| Bio-Rad Laboratories, Inc. | -608.26 Million USD | 95.481% |
| Boston Scientific Corporation | 3.45 Billion USD | 100.796% |
| Perspective Therapeutics, Inc. | -14.83 Million USD | -85.261% |
| CONMED Corporation | 182.18 Million USD | 115.088% |
| Edwards Lifesciences Corporation | 1.76 Billion USD | 101.555% |
| Paragon 28, Inc. | -36.61 Million USD | 24.922% |
| Glaukos Corporation | -82.11 Million USD | 66.524% |
| Globus Medical, Inc. | 418.23 Million USD | 106.573% |
| Inspire Medical Systems, Inc. | -17.06 Million USD | -61.131% |
| Integer Holdings Corporation | 282.05 Million USD | 109.746% |
| Medtronic plc | 9.05 Billion USD | 100.304% |
| Nevro Corp. | -78.31 Million USD | 64.897% |
| Penumbra, Inc. | 111.99 Million USD | 124.545% |
| Vicarious Surgical Inc. | -69.19 Million USD | 60.271% |
| Smith & Nephew plc | 979 Million USD | 102.808% |
| Sonendo, Inc. | -54.76 Million USD | 49.808% |
| STERIS plc | 1.41 Billion USD | 101.946% |
| Stryker Corporation | 5.16 Billion USD | 100.533% |
| Vapotherm, Inc. | -34.35 Million USD | 19.99% |
| Zimmer Biomet Holdings, Inc. | 2.44 Billion USD | 101.123% |